http://www.fpnotebook.com/
Yersinia pestisAka: Pneumonic Plague, Bubonic Plague, Plague
- Cause: Plague
- Yersinia pestis
- Pathophysiology
- Gram Negative Rod
- Bipolar staining
- Facultative anaerobic bacterium
- Incubation
- Pneumonic Plague: 2-3 days
- Bubonic Plague: 2-10 days
- Organism survival
- Viability
- Water, moist meal, grain for weeks
- Near freezing temperatures from months to years
- Dry Sputum, flea feces, buried bodies
- Killed by
- Heated for 15 minutes at 72 C
- Several hours in direct sunlight
- Transmission
- Reservoir: Rodents (rats, mice, ground squirrels)
- Fleas transmit bubonic form
- Aerosolized organisms transmit pneumonic form
- Types of plague
- Bubonic plague
- Primary septicemic plague
- Pneumonic plague
- Symptoms and signs
- Pneumonic Plague
- High fever
- Chills
- Headache
- Hemoptysis
- Toxic appearance
- Bubonic Plague
- Malaise
- High fever
- Tender lymph nodes (buboes)
- Primarily inguinal (legs most commonly flea bitten)
- Management
- Treat for 10-14 days
- Streptomycin
- Adult: 30 mg/kg/day divided q12 hours IM
- Child: 15 mg/kg (up to 2 g) IM q12 hours
- Gentamicin
- Adult: 5 mg/kg IM or IV qd
- Child: 2.5 mg/kg IM or IV q8 hours
- Doxycycline (over age 8 years)
- Convert to PO dosing when clinically improved
- Adult: 200 mg IV, then 100 mg IV q12 hours
- Child: 2.2 mg/kg IV q12 hours
- Dose as adult for children over 45 kg
- Ciprofloxacin (adults only)
- Initial: 400 mg IV q12 hours
- When improved: 750 mg PO bid
- Prevention
- Licensed, killed vaccine (no longer available)
- Doses at 0, 1-3 months, and 5-6 months
- Booster at 6 month intervals x3, then every 1-2 years
- Effective against bubonic, but not pulmonic plague
- Post-exposure prophylaxis (adult dosing below)
- Continue for 7 days or length of exposure
- Doxycycline 100 mg PO bid
- Ciprofloxacin 500 mg PO bid
- Tetracycline 500 mg PO qid
- Prognosis
- Mortality 100% if untreated
- References
- Inglesby (2000) JAMA 283:2281
|
|---|
| Definition (MSH) | An acute infectious disease caused by YERSINIA PESTIS that affects humans, wild rodents, and their ectoparasites. This condition persists due to its firm entrenchment in sylvatic rodent-flea ecosystems throughout the world. Bubonic plague is the most common form. |
| Definition (CSP) | acute infectious disease caused by Yersinia pestis that affects humans, wild rodents, and their ectoparasites; bubonic plague is the most common form. |
| Concepts | Disease or Syndrome (T047)
|
| ICD9 | 020, 020.9 |
| English | Infection by Yersinia pestis, Pest, Pestilential fever, Plague, Plague unspecified, Yersinia pestis disease |
| Spanish | infección por Yersinia pestis, infeccion por Yersinia pestis, peste, peste no especificada |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Bubonic Plague (C0282312)
|
|---|
| Concepts | Disease or Syndrome (T047)
|
| ICD9 | 020.0 |
| English | Black death, Bubonic plague, PESTIS BUBONICA, PESTIS FULMINANS |
| Spanish | peste bubónica, peste bubonica, peste fulminante, peste glandular, peste mayor |
| Credits | Derived from the NIH UMLS (Unified Medical Language System)
|
Navigation Tree